1-3 of 3
Joseph A. Fraietta
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PR001: Oncogene-induced matrix reorganization controls CD8+ T cell immunity in the UPS microenvironment

Ashley M. Fuller, Hawley C. Pruitt, Hoogeun Song, Ying Liu, Ann Devine, Rohan S. Katti, Samir Devalaraja, Gabrielle E. Ciotti, Michael Gonzalez, Erik F. Williams, Ileana Murazzi, Nicolas Skuli, Hakon Hakonarson, Kristy Weber, Malay Haldar, Joseph A. Fraietta, Sharon Gerecht, T. S. Karin Eisinger-Mathason
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (18_Supplement): PR001.
https://doi.org/10.1158/1557-3265.SARCOMAS22-PR001
Published: 15 September 2022
View article titled, Abstract PR001: Oncogene-induced matrix reorganization controls CD8<sup>+</sup> T cell immunity in the UPS microenvironment
Journal Articles

Novel Redirected T–Cell Immunotherapies for Advanced Prostate Cancer

Tanya B. Dorff, Vivek Narayan, Stephen J. Forman, Peter D. Zang, Joseph A. Fraietta, Carl H. June, Naomi B. Haas, Saul J. Priceman
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (4): 576–584.
https://doi.org/10.1158/1078-0432.CCR-21-1483
Published: 15 February 2022
View article titled, Novel Redirected T–Cell Immunotherapies for Advanced Prostate Cancer
Open the PDF for Novel Redirected T–Cell Immunotherapies for Advanced Prostate Cancer in another window
Journal Articles

The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell Lymphoma

Marco Ruella, Saad S. Kenderian, Olga Shestova, Joseph A. Fraietta, Sohail Qayyum, Qian Zhang, Marcela V. Maus, Xiaobin Liu, Selene Nunez-Cruz, Michael Klichinsky, Omkar U. Kawalekar, Michael Milone, Simon F. Lacey, Anthony Mato, Stephen J. Schuster, Michael Kalos, Carl H. June, Saar Gill, Mariusz A. Wasik
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (11): 2684–2696.
https://doi.org/10.1158/1078-0432.CCR-15-1527
Published: 31 May 2016
View article titled, The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell Lymphoma
Open the PDF for The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell Lymphoma in another window
Includes: Supplementary data